Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK-PD of Caspofungin in ICU Patients with Invasive Fungal Infection
NCT02510053Unknown
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jul 2014
- Primary completion
- Jun 2016
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
01
Overview
Open-label, single-arm trial of caspofungin in invasive fungal infection (IFI), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoints: Peak Plasma Concentration at Day 4 and Area Under the Plasma Concentration versus Time Curve at Day 4. Status: unknown.
02
Drugs
caspofungin
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT02510053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02510053.